Legal Opinion
In Re Phenylpropanolamine (PPA) Products Liability Litigation
District Court, W.D. Washington
Decided June 18, 2003No. MDL 1407PublishedCited by 36 opinions
1Opinion of the Court
ORDER GRANTING IN PART AND DENYING IN PART MDL DEFENDANTS’ MOTION TO PRECLUDE PLAINTIFFS’ EXPERT OPINIONS AS TO GENERAL CAUSATION PURSUANT TO FED. R. EVID. 702 AND 703 AND DAUBERT
ROTHSTEIN, District Judge.
I. INTRODUCTION
Defendants in this multi-district litigation filed a motion to preclude plaintiffs’ expert opinions as to general causation pursuant to Federal Rules of Evidence 702 and 703 and Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). Having reviewed pleadings filed in support of and in opposition to the motion, along with the remainder of…
2Cases cited15 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Rock v. ArkansasSupreme Court of the United States · 1987
- Charlotte KENNEDY and Robert Kennedy, Plaintiffs-Appellants, v. COLLAGEN CORPORATION, Defendant-AppelleeCourt of Appeals for the Ninth Circuit · 1998
10 more not listed; retrieve them via the Exa API.
3Cited by36 opinions
- In Re Fosamax Products Liability LitigationDistrict Court, S.D. New York · 2009
- Deutsch Ex Rel. Estate of Deutsch v. Novartis Pharmaceuticals Corp.District Court, E.D. New York · 2011
- In Re Baycol Products LitigationDistrict Court, D. Minnesota · 2007
- In Re Neurontin Marketing, Sales Practices, & Products Liability LitigationDistrict Court, D. Massachusetts · 2009
- In Re Bextra & Celebrex Marketing Sales Practices & Product Liability LitigationDistrict Court, N.D. California · 2007
31 more not listed; retrieve them via the Exa API.